iShares Biotechnology ETF (IBB)
iShares Biotechnology ETF (IBB) — healthcare and biotech ETF. Analyze it on ETF Copilot.
Tracks the U.S. biotech sector through a cap-weighted index of biotech companies.
A focused U.S. biotech position that adds growth potential to a broader health care allocation.
46% of IBB is its ten largest holdings.
Less concentrated than 65% of Healthcare & Biotech ETFs.
What's inside IBB: Size (large 46%, mid 38%, small 16%); Geography (international 14%, us 86%); AI 0.6%.
As of July 29, 2026, ETF Copilot scores iShares Biotechnology ETF (IBB) 3.8 out of 10 overall.
Updated July 29, 2026
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 3.8 / 10
- Growth: 1.0 / 10
- Valuation: 6.7 / 10
- Risk: 4.5 / 10
- Profitability: 6.0 / 10
- Return: 2.7 / 10
Register free to unlock IBB's price, fees, yield, and holdings on ETF Copilot.
Register free →